GAO: Drugmakers Say Unclear FDA Guidance Hinders Antibiotics Development

Drug Industry Daily
A A
The GAO said that a lack of clarity on the role of FDA draft guidances on antibiotic drug development creates uncertainty for drug sponsors.

To View This Article:

Login

Subscribe To Drug Industry Daily